This indicates that, also in humans, neither hypoxia nor anemia are required for the suppression of hepcidin by erythropoiesis and challenges the idea that erythropoietin induction and hepcidin inhibition are parallel effects of HIF activation. This evidence concerns the gene HAMP and anemia (phenotype).